Member Info for JustHereForHemo

You "Totally agree", then proceed to try and argue why this is a bad investment?

Seriously?

This evening what I'm getting from LSE is everyone should sell, make hemo worthless and invest like 24 hrs before they sign a huge JV in a year's time after they are in administration and cease to exist.

Maybe if people were a bit more honest and transparent with their intentions, past 48hrs hemo has attracted some bottom feeding traders hoping to stick the boot in whilst the sp is down hoping for an extra 0.5% discount so they can loaf up before ramping about how undervalued hemo is and call out the potential upside on any positive results. I don't mind being called overly optimistic however the hypocrisy of some whom know they will flip their narrative and forecast 30 seconds after buying is just disgusting.

People don't spend hours on a bb posting s417 because they need something to do sitting on the dunny, EVERYONE is here for a reason, sadly at the moment the trading trolls out number actual shareholders by quite a margin!

Well today's troll is tomorrow's buyer, I'll just apply some cream and hope I don't catch something whist I'm here 🥰

Good god, do people not read? I'm getting a rash from the level of deliberate ignorance. 20 patients DOES NOT COST 3 MILLION POUNDS. I NEVER said all phases of the trial. Nor did I say 3m would cover the rest of the day to day operations whilst trials are going on. Which is right there in black and white.

So respectfully, it's pretty obvious that half the posters today are never going to be happy, if your STILL going to be negative, post never ending c4@p and troll, at a time when the company has just loaded up on cash, have just got FDA approval??? Seriously sell up and F off!

And no. It does not cost more than 3mil to test on 20 people, please don't be thick. That's not even worth arguing about, the issue is THE REST OF THE COMPANY ALSO NEED MONEY.

Vlad needs to relist hemo in the US under a different name. All he does is attract trolls and idiots 🙄

Saint, sorry but you misunderstood me, 3m is enough to run a 20 patient trial, if the company does nothing else. Realistically they will not stop work on CBR so they need significantly more cash, but we are talking 10s of millions, not piddly 3m raises. Vlad needs to bite the bullet and licence as soon as he has a few patients treated.

3 million to run a trial with less than 20 patients using CAR-T produced in house using lentivirus they have already paid for and stock piled is more than enough. If Vlad wants to accelerate and plough cash into CBR then no its not enough, basically its up to vlad how he spends the cash and after that interview it sounds like relying on raising money via placing is hard and risky so unlikely. He has said many times however, CAR-T is for sale. At the right price. The right price comes with clinical proof and that can be after only a few patients. So will the money last? Who knows, ask vlad, either way with 15% dilution used up he can only do minimal placing for the next 12 months and that 5% includes warrants and staff incentive awards.

Guiness, would you be willing to chat sometime on the agreement that I would promise never to repeat a word here or anywhere else?

Honestly would just love to hear it from your side, are you paid are you shorting, are you just trading and want it cheaper, how much do you really make doing this etc. I swear no abuse, just an honest chat if your willing? After all at this point Hemo are solvent, no risk of dilution for quite a while and if they do sign a JV or something your efforts at that point are useless. Be nice to just meet on no mans land and have a game of football :P

Drop me an email if so: justforguiness@gmail.com

Cant help but notice you keep starting threads with stupidly low TARGET prices you want to achieve Guiness25. First 1.2p then 1.5p.

100% there is ZERO chance you are currently a shareholder, so happy days I am putting you into the "deferred buyer" pile, not sure where all these extra shares are going to come from that would have to be dumped to even get remotely close to those prices given its been almost completely flat now for 5 days with volumes down to

All well and good focusing on the automated sells, but why no mention of the automated buys?

Gee, there are no buys here every single automated trade is a sell..... No. If you have a professional account you can set up automated trading and that means sell triggers AND BUY triggers. Seen plenty of those.

If you ONLY want to focus on the automated sells? Fine, they are shares sitting in an account being managed by a bot. The are shares that are going to be sold whatever happens at some point, HOWEVER the shares are not sitting having nooky breading, they are not cells dividing and multiplying, they are not rabbits banging away. They are finite and the bot must BUY to replenish that stock.

There was a large placing, alot were forward sold and shorted sure but it was still a large placing, there was also alot of LTHers who through their heads up in disgust and just sold out, so yes there was alot of shares to clear. While the past few days feels like we have bottomed out and most of the shares are gone, there clearly are some remaining.

Comments like "long painful ride" and "probably sell the same amount to bring it back down again" are just ACES for encouraging people to buy so great job keep it up :-)

Fundamentally there is nothing wrong with Hemogenyx, its a great opportunity, especially now funded into trials with ZERO debt and 100% ownership. The ONLY thing wrong with Hemogenyx is the share price and valuation. People would not bat an eyelid or question the valuation if the mCap was £100m. So whilst I appreciate everyone has the right to moan, perhaps not dedicating every post to the same repetitive c4@p maybe a good idea? The more new investors buy the less there is for the bots to sell, its not complicated, its not rocket science. If people are going to dedicate hours and hours of their lives posting why not make it constructive and post the case for why this is a good investment.

Just had a chance to watch the interview, sharing again as its off the page:

https://www.youtube.com/watch?v=ljOknxG1mTw&ab_channel=ProactiveInvestors

Worth watching from 6:40 where he discusses future funding, interesting that he did not mention future placings but made the distinction of saying that as a clinical company there is interest from other investors and entities. He also mentioned grants and government, I want and hope to see some sort of non dilutive funding coming in the near future. Its the funding that has killed this SP and its the funding that the traders bank on to drag the SP down after any rise, ANY sort of non dilutive cash injection would be very very welcome.

HT, we did get an update on lupus, it was dropped by the partners because it was not possible to recruit patients for a trial or something like that I believe, Vlad DID tell us but I can't really remember full details.

Lol, wishful thinking on your behalf.

1, Vlad used MOST of the headroom he had in that placing so yes if he wants cash he has to swallow his pride and go and sign a licence.

2, short interest has massively decreased and the trolls/shorters are now either posting again or have flipped from deramp to ramp mode. They are traders and know much more profit to be made now buying for recovery.

3, no news for months? Lol did you get that from Vlad? 😆 they just raised 3m largely to pay to start CAR-T trials, might be a few months before we get results but expect updates on launch of trials and progress on CBR much sooner.

4, it's all irrelevant, there was just a large placing and sp tanked. Several flat days with volume going down to nothing indicator of bottom in, so say what you want, even likelihood of trial updates is irrelevant, traders will buy for the bounce once they recognise bottom is in.

When you first invested they only had CDX and HuPHEC both of which were pre clinical.... Soon.... yea there's that.

A reminder that Hemogenyx ARE clinical, a feat which was achieved on minimal budget, clinical trials will start as soon as a hospital has approved the protocol which could be days/weeks/months and the first patient is identified. Any speculation on exactly when that will be is pure speculation that includes from Hemogenyx.

Along side this they have a potential game changer with a nasal spray to deliver CBR that can treat viruses, cancer and degenerative diseases.

To say Hemo is undervalued is an understatement, however moaning about that fact is going to achieve even less than not moaning about it. Larger investors and companies wont rely on LSE for their research, but smaller PIs and traders WILL. Feel free to create a negative hostile environment, or maybe once in a while focus on the positives. Remember, most funds, who you WANT to invest here wont touch any company with a barge pole below a 50m mCap. That is not so big a reach with positivity and decent return of buyers. The chart has bottomed out with volume all but gone, seen by many traders as a good time to buy "for a trade" not welcomed or what we want, but if it helps restore the mCap back towards that 50 mark and we can start catching the eyes of some grown ups so be it!

Shicky, from what I understand Eli did not at that time want to pursue oncology, it was not on their roadmap and whilst they had fantastic early interest in CDX for many years the company moved in a different direction which meant that CDX was not going to progress very fast if Hemo waited for them. Instead they licenced all of the IP created and necessary for Hemogenyx to progress or sell CDX meaning that Hemo could look for new suitors OR progress themselves. I dont believe it had anything to do with money or valuations or even believe in the product, it just did not fit into Eli's strategic plans.

In terms of where CDX goes next, it is a new treatment which means the FDA are likely to have a long list of requirements before approving an IND, I THINK this is the main reason Hemo have not made much movement here in house, I expect the level of testing and checks demanded is going to cost alot of money which the company just cannot afford.

Which leaves them having to partner/licence/JV etc to progress, something which if they do now PRE clinical with CDX is going to attract a much lower premium, catch 22, sell it now cheap and prove it works but then you have already sold... or cant prove it works until you sell to raise enough money... Vlad has been saying for well over a year now that they are in licencing talks and you must imagine this is the issue, Vlad wont sell too cheap, and the pharma wont want to pay until they know it works!

HOWEVER.... What is important to remember is that BOTH HEMO-CAR-T and CDX are dependant on this patent:

"MONOCLONAL ANTIBODIES TO HUMAN FLT3/FLK2 RECEPTOR PROTEIN" - Basically if the current HEMO-CAR-T trials go well and validate the efficiency of the receptor chosen then there will be some validation of CDX as a by-product. Basically HEMO-CAR-T AND CDX are likely hinging on the success of these upcoming trials.

If CAR-T works then CDX is a much simpler construct, OTS and cheaper, potential to be a major disruptor to chemotherapy and much more likely to be available though Medicare and Medicaid. It will have a massive list of off label applications and should be worth billions. BUT HEMO-CAR-T is targeting a tiny patient pool with an urgent need with a proven technology that is cheaper and much faster to get FDA approval.

TL;DR Version - CDX is very much in the pipeline, but its fate is bound to HEMO-CAR-T as both use https://patents.google.com/patent/US11104738B2/en

What's funny is the people moaning today will do a 180 and be full blown bulls when it's blue and FOMO kicks in. IF today was the end of the sub placing flips then tomorrow is blue and they will have wasted all this energy being grumpy.

Why? Err because the FCA suspended my brokers licence and I didn't register anywhere else. And yes my broker was referred by peterhouse and used jarvis. I have forms to register with new broker at home, but I have been busy.

They wanted funds, they did not want to sell or license, it is not any more complicated than that. Easy to raise money if you give away your lead candidate for peanuts, vlad did not do that. As for prevail? Ask them?

False I got no sounding, that said the sounding had minimal impact until they opened up to peterhouse.

Anyway it's done, VLAD PLEASE LEARN THE LESSON, DO NOT DO PLACINGS WITH PETERHOUSE. Company are funded, those big trades look like they could be the end of whatever block they were handling, they are Clinical and next step is Clinical trials. People can be upset and grumpy, but odds look good for start of recovery tomorrow.

Indeed, banked huge profit, did fair bit of reputational damage, made it harder for the company to raise a useful amount. Well done them!

Tell us again pumpkin how people don't short hemo and traders make no difference:p